Modelling of a targeted nanotherapeutic 'stroma' to deliver the cytokine LIF, or XAV939, a potent inhibitor of Wnt-β-catenin signalling, for use in human fetal dopaminergic grafts in Parkinson's disease

Jing-Wei Zhao, Sean C Dyson, Christina Kriegel, Pam Tyers, Xiaoling He, Tarek M Fahmy, Su M Metcalfe, Roger A Barker

Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

Fingeravtryck

Fördjupa i forskningsämnen för ”Modelling of a targeted nanotherapeutic 'stroma' to deliver the cytokine LIF, or XAV939, a potent inhibitor of Wnt-β-catenin signalling, for use in human fetal dopaminergic grafts in Parkinson's disease”. Tillsammans bildar de ett unikt fingeravtryck.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science